Anticoagulants and Bleeding Disorders

Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation

Comparison of Heparin Anti-Xa Activity From Central Venous Catheter Samples Using a 5 mL Syringe Flush or a Vacuum Tube Flush Versus Peripheral Vein Samples in ICU Patients

Prospective Observational Pilot Study of LMWH Versus UFH as ECMO Anticoagulation in Lung Transplantation

MAC Project, Monitoring of AntiCoagulant Therapies (MAC)

Caudal Block & Hip Fracture Surgery in Anticoagulated Patient

Caudal Analgesia & Anticoagulated Patient

Safety and Feasibility of Argatroban As Anticoagulant in Adults with ECMO

Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy

TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study

Coagulation and Vitamin K in Head and Neck Microvascular Free Flap Surgery

Comparison of the Effect of Warfarin and Direct Oral Anticoagulants

Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari Syndrome

Bleeding Oral Anticoagulant Analyzer (BOA)

Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin

Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.

Nadroparin Pharmacokinetics in Different Stages of COVID-19

Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study

Safety of Anticoagulant Therapy After Tissue Glue for Gastric Varices

A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic

DAPHNE Study: Direct Anticoagulant PHarmacogeNEtic